Versigent (NYSE:VGNT) Research Coverage Started at The Goldman Sachs Group

The Goldman Sachs Group initiated coverage on shares of Versigent (NYSE:VGNT) in a report released on Monday morning, Marketbeat.com reports. The brokerage issued a buy rating and a $48.00 price objective on the stock.

Several other equities research analysts also recently weighed in on the stock. UBS Group reduced their target price on shares of Versigent from $58.00 to $55.00 and set a “buy” rating on the stock in a research note on Thursday, July 9th. Wall Street Zen upgraded Versigent to a “hold” rating in a report on Saturday, April 18th. BNP Paribas Exane initiated coverage on Versigent in a report on Tuesday, April 28th. They set an “outperform” rating and a $41.00 price objective for the company. Zacks Research raised Versigent from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 2nd. Finally, Deutsche Bank Aktiengesellschaft upgraded Versigent from a “hold” rating to a “buy” rating and set a $50.00 target price on the stock in a research note on Tuesday, July 7th. Three research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $49.67.

Versigent Stock Performance

Shares of NYSE VGNT opened at $41.18 on Monday. Versigent has a 12-month low of $26.34 and a 12-month high of $50.88. The firm’s 50-day simple moving average is $43.37.